-
1
-
-
0342762061
-
Regulation of the oncogenic activity of BCR-ABL by a tightly bound substrate protein RIN1
-
Afar, D. E., L. Han, J. McLaughlin, S. Wong, A. Dhaka, K. Parmar, N. Rosenberg, O. N. Witte, and J. Colicelli. 1997. Regulation of the oncogenic activity of BCR-ABL by a tightly bound substrate protein RIN1. Immunity 6:773-782.
-
(1997)
Immunity
, vol.6
, pp. 773-782
-
-
Afar, D.E.1
Han, L.2
McLaughlin, J.3
Wong, S.4
Dhaka, A.5
Parmar, K.6
Rosenberg, N.7
Witte, O.N.8
Colicelli, J.9
-
2
-
-
0032572763
-
The SH2-containing adapter protein GRB10 interacts with BCR-ABL
-
Bai, R. Y., T. Jahn, S. Schrem, G. Munzert, K. M. Weidner, J. Y. Wang, and J. Duyster. 1998. The SH2-containing adapter protein GRB10 interacts with BCR-ABL. Oncogene 17:941-948.
-
(1998)
Oncogene
, vol.17
, pp. 941-948
-
-
Bai, R.Y.1
Jahn, T.2
Schrem, S.3
Munzert, G.4
Weidner, K.M.5
Wang, J.Y.6
Duyster, J.7
-
3
-
-
0344499966
-
Inhibition of the Ras pathway by a dominant negative Ras suppresses Bcr-Abl induced myeloid but not lymphoid leukemia
-
Baum, K., X. Hao, and R. Ren. 1998. Inhibition of the Ras pathway by a dominant negative Ras suppresses Bcr-Abl induced myeloid but not lymphoid leukemia. Blood 92:94.
-
(1998)
Blood
, vol.92
, pp. 94
-
-
Baum, K.1
Hao, X.2
Ren, R.3
-
4
-
-
0029863169
-
Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl
-
Carlesso, N., D. A. Frank, and J. D. Griffin. 1996. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J. Exp. Med. 183:811-820.
-
(1996)
J. Exp. Med.
, vol.183
, pp. 811-820
-
-
Carlesso, N.1
Frank, D.A.2
Griffin, J.D.3
-
5
-
-
0031573141
-
Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients
-
Chai, S. K., G. L. Nichols, and P. Rothman. 1997. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients. J. Immunol. 159:4720-4728.
-
(1997)
J. Immunol.
, vol.159
, pp. 4720-4728
-
-
Chai, S.K.1
Nichols, G.L.2
Rothman, P.3
-
6
-
-
0003747871
-
-
John Wiley and Sons, Inc., New York, N.Y.
-
Coligan, J. E., A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober (ed.). 1996. Current protocols in immunology. John Wiley and Sons, Inc., New York, N.Y.
-
(1996)
Current Protocols in Immunology
-
-
Coligan, J.E.1
Kruisbeek, A.M.2
Margulies, D.H.3
Shevach, E.M.4
Strober, W.5
-
7
-
-
0028980342
-
Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis
-
Cortez, D., L. Kadlec, and A. M. Pendergast. 1995. Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis. Mol. Cell. Biol. 15:5531-5541.
-
(1995)
Mol. Cell. Biol.
, vol.15
, pp. 5531-5541
-
-
Cortez, D.1
Kadlec, L.2
Pendergast, A.M.3
-
8
-
-
0023263055
-
The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts
-
Daley, G. Q., J. McLaughlin, O. N. Witte, and D. Baltimore. 1987. The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts. Science 237:532-535.
-
(1987)
Science
, vol.237
, pp. 532-535
-
-
Daley, G.Q.1
McLaughlin, J.2
Witte, O.N.3
Baltimore, D.4
-
9
-
-
0025117392
-
Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome
-
Daley, G. Q., R. A. Van Etten, and D. Baltimore. 1990. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 247:824-830.
-
(1990)
Science
, vol.247
, pp. 824-830
-
-
Daley, G.Q.1
Van Etten, R.A.2
Baltimore, D.3
-
10
-
-
0026576755
-
Hematologie disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions
-
Elefanty, A. G., and S. Cory. 1992. Hematologie disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions. Mol. Cell. Biol. 12:1755-1763.
-
(1992)
Mol. Cell. Biol.
, vol.12
, pp. 1755-1763
-
-
Elefanty, A.G.1
Cory, S.2
-
11
-
-
0025271543
-
bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice
-
Elefanty, A. G., I. K. Hariharan, and S. Cory. 1990. bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice. EMBO J. 9:1069-1078.
-
(1990)
EMBO J.
, vol.9
, pp. 1069-1078
-
-
Elefanty, A.G.1
Hariharan, I.K.2
Cory, S.3
-
12
-
-
0024461553
-
Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential
-
Franz, W. M., P. Berger, and J. Y. Wang. 1989. Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential. EMBO J. 8:137-147.
-
(1989)
EMBO J.
, vol.8
, pp. 137-147
-
-
Franz, W.M.1
Berger, P.2
Wang, J.Y.3
-
13
-
-
0029087475
-
Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene
-
Goga, A., J. McLaughlin, D. E. Afar, D. C. Saffran, and O. N. Witte. 1995. Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene. Cell 82:981-988.
-
(1995)
Cell
, vol.82
, pp. 981-988
-
-
Goga, A.1
McLaughlin, J.2
Afar, D.E.3
Saffran, D.C.4
Witte, O.N.5
-
14
-
-
0029898682
-
Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia
-
Golub, T. R., A. Goga, G. F. Barker, D. E. H. Afar, J. McLaughlin, S. K. Bohlander, J. D. Rowley, O. N. Witte, and D. G. Gilliland. 1996. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol. Cell. Biol. 16:4107-4116.
-
(1996)
Mol. Cell. Biol.
, vol.16
, pp. 4107-4116
-
-
Golub, T.R.1
Goga, A.2
Barker, G.F.3
Afar, D.E.H.4
McLaughlin, J.5
Bohlander, S.K.6
Rowley, J.D.7
Witte, O.N.8
Gilliland, D.G.9
-
15
-
-
0029645577
-
The solution structure of Abl SH3, and its relationship to SH2 in the SH(32) construct
-
Gosser, Y. Q., J. Zheng, M. Overduin, B. J. Mayer, and D. Cowburn. 1995. The solution structure of Abl SH3, and its relationship to SH2 in the SH(32) construct. Structure 3:1075-1086.
-
(1995)
Structure
, vol.3
, pp. 1075-1086
-
-
Gosser, Y.Q.1
Zheng, J.2
Overduin, M.3
Mayer, B.J.4
Cowburn, D.5
-
16
-
-
0025868702
-
Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow
-
Hardy, R. R., C. E. Carmack, S. A. Shinton, J. D. Kemp, and K. Hayakawa. 1991. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173:1213-1225.
-
(1991)
J. Exp. Med.
, vol.173
, pp. 1213-1225
-
-
Hardy, R.R.1
Carmack, C.E.2
Shinton, S.A.3
Kemp, J.D.4
Hayakawa, K.5
-
17
-
-
0024309743
-
A bcr-v-abl oncogene induces lymphomas in transgenic mice
-
Hariharan, I. K., A. W. Harris, M. Crawford, H. Abud, E. Webb, S. Cory, and J. M. Adams. 1989. A bcr-v-abl oncogene induces lymphomas in transgenic mice. Mol. Cell. Biol. 9:2798-2805.
-
(1989)
Mol. Cell. Biol.
, vol.9
, pp. 2798-2805
-
-
Hariharan, I.K.1
Harris, A.W.2
Crawford, M.3
Abud, H.4
Webb, E.5
Cory, S.6
Adams, J.M.7
-
18
-
-
0025209916
-
Acute leukemia in bcr/abl transgenic mice
-
Heisterkamp, N., G. Jenster, J. ten Hoeve, D. Zovich, P. K. Pattengale, and J. Groffen. 1990. Acute leukemia in bcr/abl transgenic mice. Nature 344:251-253.
-
(1990)
Nature
, vol.344
, pp. 251-253
-
-
Heisterkamp, N.1
Jenster, G.2
Hoeve, J.T.3
Zovich, D.4
Pattengale, P.K.5
Groffen, J.6
-
19
-
-
0024520745
-
Site-directed mutagenesis by overlap extension using the polymerase chain reaction
-
Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59.
-
(1989)
Gene
, vol.77
, pp. 51-59
-
-
Ho, S.N.1
Hunt, H.D.2
Horton, R.M.3
Pullen, J.K.4
Pease, L.R.5
-
20
-
-
0028988776
-
Expression of p210bcr-abl by metallothionein promoter induced T-cell leukemia in transgenic mice
-
Honda, H., T. Fujii, M. Takatoku, H. Mano, O. N. Witte, Y. Yazaki, and H. Hirai. 1995. Expression of p210bcr-abl by metallothionein promoter induced T-cell leukemia in transgenic mice. Blood 85:2853-2861.
-
(1995)
Blood
, vol.85
, pp. 2853-2861
-
-
Honda, H.1
Fujii, T.2
Takatoku, M.3
Mano, H.4
Witte, O.N.5
Yazaki, Y.6
Hirai, H.7
-
21
-
-
0032520986
-
Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210bcr/abl: A novel transgenic model for human Ph1-positive leukemias
-
Honda, H., H. Oda, T. Suzuki, T. Takahashi, O. N. Witte, K. Ozawa, T. Ishikawa, Y. Yazaki, and H. Hirai. 1998. Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210bcr/abl: a novel transgenic model for human Ph1-positive leukemias. Blood 91:2067-2075.
-
(1998)
Blood
, vol.91
, pp. 2067-2075
-
-
Honda, H.1
Oda, H.2
Suzuki, T.3
Takahashi, T.4
Witte, O.N.5
Ozawa, K.6
Ishikawa, T.7
Yazaki, Y.8
Hirai, H.9
-
22
-
-
0000506439
-
P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members
-
Ilaria, R. L., Jr., and R. A. Van Etten. 1996. P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J. Biol. Chem. 271:31704-31710.
-
(1996)
J. Biol. Chem.
, vol.271
, pp. 31704-31710
-
-
Ilaria R.L., Jr.1
Van Etten, R.A.2
-
23
-
-
0024343691
-
N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl
-
Jackson, P., and D. Baltimore. 1989. N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMBO J. 8:449-456.
-
(1989)
EMBO J.
, vol.8
, pp. 449-456
-
-
Jackson, P.1
Baltimore, D.2
-
24
-
-
0025187837
-
Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL
-
Kelliher, M. A., J. McLaughlin, O. N. Witte, and N. Rosenberg. 1990. Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL. Proc. Natl. Acad. Sci. USA 87:6649-6653.
-
(1990)
Proc. Natl. Acad. Sci. USA
, vol.87
, pp. 6649-6653
-
-
Kelliher, M.A.1
McLaughlin, J.2
Witte, O.N.3
Rosenberg, N.4
-
25
-
-
0027280685
-
ABL oncogenes directly stimulate two distinct target cells in bone marrow from 5-fluorouracil-treated mice
-
Kelliher, M. A., D. J. Weckstein, A. G. Knott, H. H. Wortis, and N. Rosenberg. 1993. ABL oncogenes directly stimulate two distinct target cells in bone marrow from 5-fluorouracil-treated mice. Oncogene 8:1249-1256.
-
(1993)
Oncogene
, vol.8
, pp. 1249-1256
-
-
Kelliher, M.A.1
Weckstein, D.J.2
Knott, A.G.3
Wortis, H.H.4
Rosenberg, N.5
-
26
-
-
0027512425
-
BCR-ABL tyrosine kinase is autophosphorylated or transphosphorylates P160 BCR on tyrosine predominantly within the first BCR exon
-
Liu, J., M. Campbell, J. Q. Guo, D. Lu, Y. M. Xian, B. S. Andersson, and R. B. Arlinghaus. 1993. BCR-ABL tyrosine kinase is autophosphorylated or transphosphorylates P160 BCR on tyrosine predominantly within the first BCR exon. Oncogene 8:101-109.
-
(1993)
Oncogene
, vol.8
, pp. 101-109
-
-
Liu, J.1
Campbell, M.2
Guo, J.Q.3
Lu, D.4
Xian, Y.M.5
Andersson, B.S.6
Arlinghaus, R.B.7
-
27
-
-
0030067346
-
Inhibition of Bcr serine kinase by tyrosine phosphorylation
-
Liu, J., Y. Wu, G. Z. Ma, D. Lu, L. Haataja, N. Heisterkamp, J. Groffen, and R. B. Arlinghaus. 1996. Inhibition of Bcr serine kinase by tyrosine phosphorylation. Mol. Cell. Biol. 16:998-1005.
-
(1996)
Mol. Cell. Biol.
, vol.16
, pp. 998-1005
-
-
Liu, J.1
Wu, Y.2
Ma, G.Z.3
Lu, D.4
Haataja, L.5
Heisterkamp, N.6
Groffen, J.7
Arlinghaus, R.B.8
-
28
-
-
0025942490
-
The Bcr gene encodes a novel serine/threonine kinase activity within a single exon
-
Maru, Y., and O. N. Witte. 1991. The Bcr gene encodes a novel serine/threonine kinase activity within a single exon. Cell 67:459-468.
-
(1991)
Cell
, vol.67
, pp. 459-468
-
-
Maru, Y.1
Witte, O.N.2
-
29
-
-
0027422977
-
A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins
-
McWhirter, J. R., D. L. Galasso, and J. Y. Wang. 1993. A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Mol. Cell. Biol. 13:7587-7595.
-
(1993)
Mol. Cell. Biol.
, vol.13
, pp. 7587-7595
-
-
McWhirter, J.R.1
Galasso, D.L.2
Wang, J.Y.3
-
30
-
-
0025924674
-
Activation of tyrosine kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins
-
McWhirter, J. R., and J. Y. Wang. 1991. Activation of tyrosine kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins. Mol. Cell. Biol. 11:1553-1565.
-
(1991)
Mol. Cell. Biol.
, vol.11
, pp. 1553-1565
-
-
McWhirter, J.R.1
Wang, J.Y.2
-
31
-
-
0030670095
-
Effect of Bcr sequences on the cellular function of the Bcr-Abl oncoprotein
-
McWhirter, J. R., and J. Y. Wang. 1997. Effect of Bcr sequences on the cellular function of the Bcr-Abl oncoprotein. Oncogene 15:1625-1634.
-
(1997)
Oncogene
, vol.15
, pp. 1625-1634
-
-
McWhirter, J.R.1
Wang, J.Y.2
-
32
-
-
0029816460
-
The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype
-
Melo, J. V. 1996. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 88:2375-2384.
-
(1996)
Blood
, vol.88
, pp. 2375-2384
-
-
Melo, J.V.1
-
33
-
-
0028485085
-
High-resolution crystal structures of tyrosine kinase SH3 domains complexed with proline-rich peptides
-
Musacchio, A., M. Saraste, and M. Wilmanns. 1994. High-resolution crystal structures of tyrosine kinase SH3 domains complexed with proline-rich peptides. Nat. Struct. Biol. 1:546-551.
-
(1994)
Nat. Struct. Biol.
, vol.1
, pp. 546-551
-
-
Musacchio, A.1
Saraste, M.2
Wilmanns, M.3
-
34
-
-
0032533257
-
Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow
-
Pear, W. S., J. P. Miller, L. Xu, J. C. Pui, B. Soffer, R. C. Quackenbush, A. M. Pendergast, R. Bronson, J. C. Aster, M. L. Scott, and D. Baltimore. 1998. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood 92:3780-3792.
-
(1998)
Blood
, vol.92
, pp. 3780-3792
-
-
Pear, W.S.1
Miller, J.P.2
Xu, L.3
Pui, J.C.4
Soffer, B.5
Quackenbush, R.C.6
Pendergast, A.M.7
Bronson, R.8
Aster, J.C.9
Scott, M.L.10
Baltimore, D.11
-
35
-
-
0027236954
-
Production of high-titer helper-free retroviruses by transient transfection
-
Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
-
(1993)
Proc. Natl. Acad. Sci. USA
, vol.90
, pp. 8392-8396
-
-
Pear, W.S.1
Nolan, G.P.2
Scott, M.L.3
Baltimore, D.4
-
36
-
-
0025766195
-
BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner
-
Pendergast, A. M., A. J. Muller, M. H. Havlik, Y. Maru, and O. N. Witte. 1991. BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner. Cell 66:161-171.
-
(1991)
Cell
, vol.66
, pp. 161-171
-
-
Pendergast, A.M.1
Muller, A.J.2
Havlik, M.H.3
Maru, Y.4
Witte, O.N.5
-
37
-
-
0027368352
-
BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the Grb-2 adapter protein
-
Pendergast, A. M., L. A. Quilliam, L. D. Cripe, C. H. Bassing, Z. Dai, N. Li, A. Batzer, K. M. Rabun, C. J. Der, J. Schlessinger, and M. L. Gishizky. 1993. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the Grb-2 adapter protein. Cell 75:175-185.
-
(1993)
Cell
, vol.75
, pp. 175-185
-
-
Pendergast, A.M.1
Quilliam, L.A.2
Cripe, L.D.3
Bassing, C.H.4
Dai, Z.5
Li, N.6
Batzer, A.7
Rabun, K.M.8
Der, C.J.9
Schlessinger, J.10
Gishizky, M.L.11
-
38
-
-
0031884893
-
A new case of chronic myeloid leukemia (CML) in myeloid blast crisis with an atypical (b3/a3) junction of the BCR/ABL gene
-
Polak, J., Z. Zemanova, K. Michalova, H. Klamova, J. Cermak, and C. Haskovec. 1998. A new case of chronic myeloid leukemia (CML) in myeloid blast crisis with an atypical (b3/a3) junction of the BCR/ABL gene. Leukemia 12:250.
-
(1998)
Leukemia
, vol.12
, pp. 250
-
-
Polak, J.1
Zemanova, Z.2
Michalova, K.3
Klamova, H.4
Cermak, J.5
Haskovec, C.6
-
39
-
-
0028147448
-
Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway
-
Pull, L., J. Liu, G. Glsh, G. Mbamalu, D. Bowtell, P. G. Pelicci, R. Arlinghaus, and T. Pawson. 1994. Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway. EMBO J. 13:764-773.
-
(1994)
EMBO J.
, vol.13
, pp. 764-773
-
-
Pull, L.1
Liu, J.2
Glsh, G.3
Mbamalu, G.4
Bowtell, D.5
Pelicci, P.G.6
Arlinghaus, R.7
Pawson, T.8
-
40
-
-
0031561479
-
Signal transduction by wild-type and leukemogenic Abl proteins
-
Raitano, A. B., Y. E. Whang, and C. L. Sawyers. 1997. Signal transduction by wild-type and leukemogenic Abl proteins. Biochim. Biophys. Acta 1333: F201-F216.
-
(1997)
Biochim. Biophys. Acta
, vol.1333
-
-
Raitano, A.B.1
Whang, Y.E.2
Sawyers, C.L.3
-
41
-
-
0026739538
-
Oncogenic v-Abl tyrosine kinase can inhibit or stimulate growth, depending on the cell context
-
Renshaw, M. W., E. T. Kipreos, M. R. Albrecht, and J. Y. Wang. 1992. Oncogenic v-Abl tyrosine kinase can inhibit or stimulate growth, depending on the cell context. EMBO J. 11:3941-3951.
-
(1992)
EMBO J.
, vol.11
, pp. 3941-3951
-
-
Renshaw, M.W.1
Kipreos, E.T.2
Albrecht, M.R.3
Wang, J.Y.4
-
42
-
-
0028881598
-
The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation
-
Renshaw, M. W., J. R. McWhirter, and J. Y. Wang. 1995. The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation. Mol. Cell. Biol. 15:1286-1293.
-
(1995)
Mol. Cell. Biol.
, vol.15
, pp. 1286-1293
-
-
Renshaw, M.W.1
McWhirter, J.R.2
Wang, J.Y.3
-
43
-
-
0028127003
-
Association of the protein kinases c-Bcr and Bcr-Abl with proteins of the 14-3-3 family
-
Reuther, G. W., H. Fu, L. D. Cripe, R. J. Collier, and A. M. Pendergast. 1994. Association of the protein kinases c-Bcr and Bcr-Abl with proteins of the 14-3-3 family. Science 266:129-133.
-
(1994)
Science
, vol.266
, pp. 129-133
-
-
Reuther, G.W.1
Fu, H.2
Cripe, L.D.3
Collier, R.J.4
Pendergast, A.M.5
-
44
-
-
0017111732
-
A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus
-
Rosenberg, N., and D. Baltimore. 1976. A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus. J. Exp. Med. 143:1453-1463.
-
(1976)
J. Exp. Med.
, vol.143
, pp. 1453-1463
-
-
Rosenberg, N.1
Baltimore, D.2
-
45
-
-
0024202338
-
The viral and cellular forms of the Abelson (abl) oncogene
-
Rosenberg, N., and O. N. Witte. 1988. The viral and cellular forms of the Abelson (abl) oncogene. Adv. Virus Res. 35:39-81.
-
(1988)
Adv. Virus Res.
, vol.35
, pp. 39-81
-
-
Rosenberg, N.1
Witte, O.N.2
-
46
-
-
0033614446
-
Chronic myeloid leukemia
-
Sawyers, C. L. 1999. Chronic myeloid leukemia. N. Engl. J. Med. 340:1330-1340.
-
(1999)
N. Engl. J. Med.
, vol.340
, pp. 1330-1340
-
-
Sawyers, C.L.1
-
47
-
-
0025951063
-
v-abl causes hematopoietic disease distinct from that caused by bcr-abl
-
Scott, M. L., R. A. Van Etten, G. Q. Daley, and D. Baltimore. 1991. v-abl causes hematopoietic disease distinct from that caused by bcr-abl. Proc. Natl. Acad. Sci. USA 88:6506-6510.
-
(1991)
Proc. Natl. Acad. Sci. USA
, vol.88
, pp. 6506-6510
-
-
Scott, M.L.1
Van Etten, R.A.2
Daley, G.Q.3
Baltimore, D.4
-
48
-
-
0029810923
-
Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia
-
Shuai, K., J. Halpern, J. ten Hoeve, X. Rao, and C. L. Sawyers. 1996. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene 13:247-254.
-
(1996)
Oncogene
, vol.13
, pp. 247-254
-
-
Shuai, K.1
Halpern, J.2
Ten Hoeve, J.3
Rao, X.4
Sawyers, C.L.5
-
49
-
-
0030710188
-
Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway
-
Skorski, T., A. Bellacosa, M. Nieborowska-Skorska, M. Majewski, R. Martinez, J. K. Choi, R. Trotta, P. Wlodarski, D. Perrotti, T. O. Chan, M. A. Wasik, P. N. Tsichlis, and B. Calabretta. 1997. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway. EMBO J. 16:6151-6161.
-
(1997)
EMBO J.
, vol.16
, pp. 6151-6161
-
-
Skorski, T.1
Bellacosa, A.2
Nieborowska-Skorska, M.3
Majewski, M.4
Martinez, R.5
Choi, J.K.6
Trotta, R.7
Wlodarski, P.8
Perrotti, D.9
Chan, T.O.10
Wasik, M.A.11
Tsichlis, P.N.12
Calabretta, B.13
-
50
-
-
0031982854
-
The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: Role in adhesion, invasion, and homing
-
Skorski, T., M. Nieborowska-Skorska, P. Wlodarski, M. Wasik, R. Trotta, P. Kanakaraj, P. Salomoni, M. Antonyak, R. Martinez, M. Majewski, A. Wong, B. Perussia, and B. Calabretta. 1998. The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing. Blood 91:406-418.
-
(1998)
Blood
, vol.91
, pp. 406-418
-
-
Skorski, T.1
Nieborowska-Skorska, M.2
Wlodarski, P.3
Wasik, M.4
Trotta, R.5
Kanakaraj, P.6
Salomoni, P.7
Antonyak, M.8
Martinez, R.9
Majewski, M.10
Wong, A.11
Perussia, B.12
Calabretta, B.13
-
52
-
-
0028789703
-
BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice
-
Voncken, J. W., V. Kaartinen, P. K. Pattengale, W. T. Germeraad, J. Groffen, and N. Heisterkamp. 1995. BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice. Blood 86:4603-4611.
-
(1995)
Blood
, vol.86
, pp. 4603-4611
-
-
Voncken, J.W.1
Kaartinen, V.2
Pattengale, P.K.3
Germeraad, W.T.4
Groffen, J.5
Heisterkamp, N.6
-
53
-
-
0030803669
-
The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity
-
Wen, S. T., and R. A. Van Etten. 1997. The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Genes Dev. 11:2456-2467.
-
(1997)
Genes Dev.
, vol.11
, pp. 2456-2467
-
-
Wen, S.T.1
Van Etten, R.A.2
-
54
-
-
0032495554
-
Requirement of two specific tyrosine residues for the catalytic activity of bcr serine/threonine kinase
-
Wu, Y., J. Liu, and R. B. Arlinghaus. 1998. Requirement of two specific tyrosine residues for the catalytic activity of Bcr serine/threonine kinase. Oncogene 16:141-146.
-
(1998)
Oncogene
, vol.16
, pp. 141-146
-
-
Wu, Y.1
Liu, J.2
Arlinghaus, R.B.3
-
55
-
-
0032533620
-
Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: A novel model for chronic myelogenous leukemia
-
Zhang, X., and R. Ren. 1998. Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia. Blood 92:3829-3840.
-
(1998)
Blood
, vol.92
, pp. 3829-3840
-
-
Zhang, X.1
Ren, R.2
|